Go to home page - PHARMAC - Pharmaceutical Management Agency
Leading Edge Medicines Management home
Patients & Consumers Health Professionals District Health Boards Pharmaceutical Suppliers

Thu Feb 9 2012 NZST

Search term:

2009 / 02

PHARMAC documents that matched your search:

Prev, Next – Page 1 of 2 (20 documents)

icon

Consultation letter for AFT multi product agreement closes 13 March 2009 (3 pages, 160 KB)
2009/02/27
archive, consultation

27 February 2009 Multi-product proposal including the listing of new brands of cilazapril and propofol and funding for danthron with poloxamer PHARMAC and AFT Pharmaceuticals Ltd have entered into a provisional agreement relating to the supply of arsenic trioxide (AFT),…

text


icon

NRT Wider Access Consultation closes 13 March 2009 (4 pages, 157 KB)
2009/02/27
archive, consultation

27 February 2009 Proposed changes to the funding of nicotine replacement therapy (funded via prescription – changes to pharmacist reimbursement) Proposal Summary Currently nicotine replacement therapy (NRT) is listed on the Pharmaceutical Schedule but is only subsidised on a “Quitcard”,…

text


icon

Tender Notification (2 pages, 111 KB)
2009/02/27
archive, notification

FAX Tender Results To: From: Date: All Suppliers and Wholesalers Yvonne Chen 27 February 2009 No of Pages (including this one): 2 Dear Supplier/Wholesaler TENDER RESULTS The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders…

text


icon

Special Circumstance Application form for Acitretin/Isotretinoin (1 page, 97 KB)
2009/02/26

Special Circumstance Application form for Acitretin/Isotretinoin Please fax this form to: Ministry of Health, Sector Services – 0800 100 131 Note: The Special Circumstance approval number will only cover repeat dispensings of acitretin or isotretinoin where the original was dispensed…

text


icon

Notification Acitretin, Bezafibrate, Diazepam and Disulfiram Proposal (1 page, 142 KB)
2009/02/24
archive, notification

23 February 2009 Acitretin, Bezafibrate, Diazepam and Disulfiram proposal approved PHARMAC is pleased to announce the approval of a supply agreement with Actavis Australia Ltd for the supply of acitretin (Neotigason), bezafibrate (Bezalip Retard), diazepam (Stesolid) and disulfiram (Antabuse). Summary…

text


icon

Notification of glibenclamide (Daonil) Funding Proposal (1 page, 139 KB)
2009/02/24
archive, notification

23 February 2009 Glibenclamide (Daonil) funding proposal approved PHARMAC is pleased to announce the approval of a supply agreement with Sanofi Aventis for glibenclamide 5 mg tablets (Daonil). Daonil is a sulphonylurea used in the treatment of diabetes. Summary of…

text


icon

Changes to growth hormone access criteria for patients with Prader-Willi Syndrome (3 pages, 115 KB)
2009/02/20
archive, notification

19 February 2009 Changes to growth hormone access criteria for patients with Prader-Willi Syndrome PHARMAC is pleased to announce changes to the current growth hormone access criteria for patients with Prader-Willi Syndrome (PWS), effective 1 March 2009. These changes have…

text


icon

Schedule Update - effective 1 March 2009 (46 pages, 467 KB)
2009/02/20
SchedulePublications, update

Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 March 2009 Cumulative for January, February and March 2009 Section H cumulative for December 2008 and January, February and March 2009. Contents Summary of PHARMAC decisions effective 1 March 2009…

text


icon

Notification: Agreement with AstraZeneca for water for injection and Marcain with adrenaline (2 pages, 126 KB)
2009/02/10
archive, notification

10 February 2009 Agreement with AstraZeneca for water for injection and Marcain with adrenaline approved PHARMAC is pleased to announce the approval of an agreement with AstraZeneca for the listing of water for injection, and Hospital Supply Status for Marcain…

text


icon

Notification of Roche ACP: filgrastim, pegfilgrastim, Midazolam and mycophenolate (2 pages, 63 KB)
2009/02/09
archive, notification

9 Febuary 2009 Agreement with Roche for filgrastim, midazolam, mycophenolate mofetil and pegfilgrastim PHARMAC is pleased to announce the approval of an agreement with Roche Products Limited. The proposal will result in: Hospital Supply Status for the Neupogen brand of…

text


Prev, Next – Page 1 of 2 (20 documents)

Search tips

Search or Browse

To search for a document enter a search term into the search form and activate the Search button.

Documents may be browsed by date, eg; Today, February, 2012.

Past years can be browsed too...
2011, 2010, 2009, 2008, 2007, 2006, 2005, 2004, 2003, 2002, 2001, 2000, 1999, 1998.

Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg;
Media releases from 2012

Search terms

Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.

Document tags (shown in bolded red below document date) have highest priority when search results are ranked, followed by title, abstract and full text of document (if available). Tags in use include...
AnnualReview, archive, BoardPaper, BusinessPlan, CAC, CACminutes, CCNotifications, ClinNewsletter, consultation, EC, ECForm, EOI, etender, herceptin, inpharmation, leaflet, LetterOfExpectations, media, notification, OIA, OutputAgreement, PatientGuide, policy, poster, PTAC, PTACminutes, PTACSCMinutes, Q&A, release, resource, RFI, RFP, SAForm, SAForms, schedule, ScheduleDispatch, SchedulePublications, SectionH, SOI, tender, update, vacancy, WhatsNew.

Documents with related dates can be browsed through the date component links below the document title.

Remember to group or statements with parentheses if they are beside and statements.

Search examples

consultation
Search for consultations
media and not antibiotics
Search for media related documents that don't mention antibiotics.
(media or consultation) and vaccines
Search for media releases and consultation documents mentioning vaccinations.